No attenuation of ischaemic preconditioning by the calcium antagonist nisoldipine

Journal of Molecular and Cellular Cardiology

Volumn 28, Issue 8, 1996, Pages 1801-1810

  Wallbridge, David R ^b   Schulz, Rainer ^b   Braun, Christian ^b   Post, Heiner ^b   Heusch, Gerd ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b NONE

Author keywords

Calcium; Calcium antagonists; Infarction; Ischaemia; Nisoldipine; Pigs; Preconditioning

Indexed keywords

CALCIUM ANTAGONIST; NISOLDIPINE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ENDOCARDIUM; FEMALE; HEART INDEX; HEART INFARCTION SIZE; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART WORK; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE;

ANIMALIA; CANIS FAMILIARIS; SUS SCROFA;

EID: 0030219863     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1996.0169     Document Type: Article

References (66)

1. AMENDE I, BENTIVEGNA LA, ZEIND AJ, WENZLAFF P, GROSSMAN W, MORGAN JP, 1992. Intracellular calcium and ventricular function. Effects of nisoldipine on global ischaemia in the isovolumic, coronary-perfused hearts. J Clin Invest 89: 2060-2065.
2. 2+ paradox injury in rat heart. Role of adenosine. Circ Res 74: 360-367.
3. ATP channels, and ischaemic preconditioning in dogs. Am J Physiol 264: H1327-336.
4. BAUMGART D, EHRING T, HEUSCH G, 1993. A proischaemic action of nisoldipine: relationship to a decrease in perfusion pressure and comparison to dipyridamole. Cardiovasc Res 27: 1254-9.
5. BOLLI R, 1990. Mechanism of myocardial "stunning". Circulation 82: 723-738.
6. BUSH LR, ROMSON JL, ASH JL, LUCCHESI BR, 1982. Effects of diltiazem on extent of ultimate myocardial injury resulting from temporary coronary artery occlusion in dogs. J Cardiovasc Pharmacol 4: 285-296.
7. COHEN MV, LIU GS, DOWNEY JM, 1991. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84: 341-349.
8. DAVENPORT NC, GOLDSTEIN RE, BOLLI R, EPSTEIN SE, 1984. Blood flow to infarct and surviving myocardium: implications regarding the action of verapamil on the acutely ischaemic dog heart. J Am Coll Cardiol 3: 956-965.
9. DU TOIT EF, OPIE LH, 1992. Modulation of the severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at the onset of reperfusion. Circ Res 70: 960-967.
10. EHRING T, BÖHM M, HEUSCH G, 1992. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischaemia. J Cardiovasc Pharmacol 20: 63-74.
11. FERRARI R, CURELLO S, CECONI C, CARGNONI A, PASINI E, VISIOLI O, 1993. Cardioprotection by nisoldipine: role of timing of administration. Eur Heart J 14: 1258-1272.
12. FURBERG CD, PSATY BM, MEYER JV, 1995. Nifedipine. Dose-related increase in mortality in patients with coronary artery disease. Circulation 92: 1326-1331.
13. GARCIA-DORADO D, THEROUX P, FERNANDEZ-AVILES F, ELIZAGA J, SOLARES J, GALIANNES M, 1987. Diltiazem and progression of myocardial ischaemic damage during coronary artery occlusion and reperfusion in porcine hearts. J Am Coll Cardiol 10: 906-911.
14. GEARY GG, SMITH GT, SUEHIRO GT, MCNAMARA JJ, 1982. Failure of nifedipine therapy to reduce myocardial infarct size in the baboon. Am J Cardiol 49: 331-338.
15. GOTO M, LIU Y, YANG X, ARDELL JL, COHEN MV, DOWNEY JM, 1995. Role of bradykinin in protection of ischaemic precondition in g in rabbit hearts. Circ Res 77: 611-621.
16. GROSS GJ, AUCHAMPACH JA, 1992. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 70: 223-233.
17. HELD PH, YUSUF S, 1994. Calcium antagonists in the treatment of ischemic heart disease: myocardial infarction. Coronary Artery Dis 5: 21-26.
18. HEUSCH G, 1992. Myocardial stunning: a role for calcium antagonists during ischaemia? Cardiovasc Res 26: 14-19.
19. HEUSCH G, ROSE J, SKYSCHALLY A, POST H, SCHULZ R, 1996. Calcium responsiveness in regional myocardial short-term hibernation and stunning in the in situ porcine heart. Inotropic responses to postextrasystolic potendation and intracoronary calcium. Circulation 93: 1556-1566.
20. JENNINGS RB, 1969. Early phase of myocardial ischaemic injury and infarction. Am J Cardiol 24: 753-756.
21. KITAKAZE M, MARBAN E, 1989. Cellular mechanism of the modulation of contractile function by coronary perfusion pressure in ferret hearts. J Physiol 414: 455-472.
22. 1-adrenoceptor activation mediates the infarct size limiting effect of ischaemic preconditioning through augmentation of 5′-nucleotidase activity. J Clin Invest 93: 2197-2207.
23. KLEIN HH, SCHUBOTHE M, NEBENDAHL K, KREUZER H, 1984. The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts. Circulation 69: 1000-1005.
24. KLONER RA, BRAUNWALD E, 1987. Effects of calcium antagonists on infarcting myocardium. Am J Cardiol 59[Suppl B]: 84-94.
25. KLONER RA, 1995. Nifedipine in ischemic heart disease. Circulation 92: 1074-1078.
26. KLONER RA, SHOOK T, PRZYKLENK K, DAVIS VG, JUNIO L, MATTHEWS RV, BURSTEIN S, GIBSON CM, POOLE WK, CANNON CP, MCCABE CH, BRAUNWALD E, 1995. Previous angina alters in-hospital outcome in TIMI 4: a clinical correlate to preconditioning? Circulation 91: 37-45.
27. KOJIMA S, WU ST, WATTERS TA, PARMLEY WW, WIKMAN-COFFELT J, 1993. Effects of perfusion pressure on intracellular calcium, energetics, and function in perfused rat hearts. Am J Physiol 264: H183-H189.
28. KRAUSE S, HESS ML, 1984. Characterisation of cardiac sarcoplasmic reticulum dysfunction during short-term, normothermic, global ischaemia. Circ Res 55: 176-184.
29. KRAUSE SM, JACOBUS WE, BECKER LC, 1989. Alterations in cardiac sarcoplasmic reticulum calcium transport in the postischemic "stunned" myocardium. Circ Res 65: 526-530.
30. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79: 950-961.
31. Li Y, WHITTAKER P, KLONER RA, 1992. The transient nature of the effect of ischemic preconditioning on myocardial infarct size and ventricular arrhythmias. Am Heart J 123: 346-353.
32. LIU GS, THORNTON J, VAN WINKLE DM, STANLEY AWH, OLSSON RA, DOWNEY JM, 1991. Protection against infarction afforded by preconditioning is mediated via Al adenosine receptors in rabbit heart. Circulation 84: 350-356.
33. LIU Y, TSUCHIDA A, COHEN MV, DOWNEY JM, 1995. Pretreatment with angiotensin II activates protein kinase C and limits myocardial infarction in isolated rabbit hearts. J Moll Cell Cardiol 27: 883-892.
34. MARBAN E, 1991. Myocardial stunning and hibernation. The physiology behind the colloquialisms. Circulation 83: 681-688.
35. MURRY CE, JENNINGS RB, REIMER KA, 1986. Preconditioning with ischaemia: a delay of lethal cell injury in ischaemic myocardium. Circulation 74: 1124-1136.
36. NAYLER WG, 1981. The role of calcium in the ischaemic myocardium. Am J Pathol 102: 262-270.
37. 2+ mediate the infarct size-limiting effect in the canine hearts. (Abstract). Circulation 90 (Suppl I): 1-209.
38. NOLL F, 1970. L-Lactat. Bestimmung mit LDH, GPT und NAD. In : Bergmeyer HV, ed. Methoden der enzymatischen Analyse, Weinheim, Germany: Verlag Chemie: 1433-1437.
39. OPIE LH, MESSERLI FH, 1995. Nifedipine and mortality. Grave defects in the dossier. Circulation 92: 1068-1073.
40. PARK S-W, TANG X-L, QIU Y, SUN J-Z, BOLLI R, 1996. Direct protective effects of nisoldipine against myocardial stunning induced by multiple coronary occlusions in conscious pigs. J Mol Cell Cardiol 28: 655-666.
41. PRZYKLENK K, KLONER RA, 1992. Calcium antagonists and the stunned myocardium: a role during ischaemia? A role during reperfusion? (Letter). Cardiovasc Res 26: 82-84.
42. REIMER KA, LOWE JE, RASMUSSEN MM, JENNINGS RB, 1977. The wavefront phenomenon of ischemic cell death. Myocardial infarct size vs during of coronary occlusion in dogs. Circulation 56: 786-794.
43. REIMER KA, JENNINGS RB, 1984. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Lab Invest 51: 655-666.
44. REIMER KA, JENNINGS RB, COBB FR, MURDOCK RH, GREENFIELD JC, BECKER LC, HEALY BULKLEY B, HUTCHINS GM, SCHWARTZ RP, BAILEY KR, PASSAMANI ER, 1985. Animal models for protecting ischaemic myocardium: results of the NHLBI cooperative study. Circ Res 56: 651-665.
45. SCHAPER W, GÖRGE G, WINKLER B, SCHAPER J, 1988. The collateral circulation of the heart. Prog Cardiovasc Dis 31: 57-77.
46. SCHOTT RJ, ROHMANN S, BRAUN ER, SCHAPER W, 1990. Ischemic preconditioning reduced infarct size in swine myocardium. Circ Res 66: 1133-42.
47. SCHULZ R, MIYAZAKI S, MILLER M, THAULOW E, HEUSCH G, ROSS J JR, GUTH BD, 1989. Consequences of regional inotropic stimulation of ischemic myocardium on regional myocardial blood flow and function in anesthetized swine. Circ Res 64: 1116-1126.
48. SCHULZ R, ROSE J, MARTIN C, BRODDE OE, HEUSCH G, 1993. Development of short-term myocardial hibernation: its limitation by the severity of ischemia and inotropic stimulation. Circulation 88: 684-695.
49. SCHULZ R, ROSE J, HEUSCH G, 1995. Involvement of activation of ATP-dependent potassium channels in ischemic preconditioning in swine. Am J Physiol 267: H1341-H1352.
50. SCHULZ R, ROSE J, POST H, HEUSCH G, 1995. Involvement of endogenous adenosine in ischaemic preconditioning in swine. Pflugers Arch-Eur J Physiol 430: 273-282.
51. SERRUYS PW, SURYAPRANATA H, PLANELLAS J, WIJNS W, VANHALEWEYK GL, JASKI BE, HUGENHOLTZ PG, 1985. Acute effects of intravenous nisoldipine on left ventricular function and coronary haemodynamics. Am J Cardiol 56: 140-146.
52. SHEN C, JENNINGS RB, 1972. Myocardial calcium and magnesium in acute ischaemic injury. Am J Pathol 67: 417-440.
53. SKYSCHALLY A, SCHULZ R, HEUSCH G, 1993. Cordat II: a new program for data acquisition and on-line calculation of hemodynamic and regional myocardial dimension parameters. Comput Biol Med 23: 359-367.
54. + channel. Studies of contractile function after simulated ischaemia in an atrial in vitro model. Circ Res 77: 1030-1035.
55. STEENBERGEN C, MURPHY E, LEVY L, LONDON RE, 1987. Elevation in cytosolic free calcium concentration early in myocardial ischaemia in perfused rat hearts. Circ Res 60: 700-707.
56. STEENBERGEN C, PERLMAN ME, LONDON RE, MURPHY E, 1993. Mechanism of preconditioning. Ionic alterations. Circ Res 72: 112-125.
57. 2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Circ Res 65: 1045-1056.
58. The Danish Study Group on Verapamil in Myocardial Infarction, 1990. Effect of verapamil on mortality and major events after acute myocardial infarction (The Danish Verapamil Infarction Trial II-Davit II). Am J Cardiol 66: 779-785.
59. THEROUX P, ROSS J JR, FRANKLIN D, KEMPER WS, SASAYAMA S, 1976. Regional myocardial function in the conscious dog during acute coronary occlusion and responses to morphine, propranolol, nitroglycerin, and lidocaine. Circulation 53: 302-314.
60. THORNTON JD, LIU GS, DOWNEY JM, 1993. Pretreatment with pertussis toxin blocks the protective effects of preconditioning: evidence for a G-protein mechanism. J Mol Cell Cardiol 25: 311-320.
61. 1 Adrenergic agonists precondition rabbit ischaemic myocardium independent of adenosine by direct activation of protein kinase C. Circ Res 75: 576-85.
62. TUMAS J, DETH R, KLONER RA, 1985. Effects of nisoldipine, a new calcium antagonist, on myocardial infarct size and cardiac dynamics following acute myocardial infarction. J Cardiovasc Pharmacol 7: 361-367.
63. WALL TM, SHEEHY R, HARTMAN JC, 1994. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 270: 681-689.
64. + channel in mediating the effects of acetylcholine to mimic preconditioning in dogs. Circ Res 73: 1193-1201.
65. YELLON DM, ALKHULAIFA M, BROWNE EE, PUGSLEY WB, 1992. Ischaemic preconditioning limits infarct size in the rat heart. Cardiovasc Res 26: 983-987.
66. YOSHIDA S, DOWNEY JM, FRIEDMAN FR, CHAMBERS DE, HEARSE DJ, YELLON DM, 1985. Nifedipine limits infarct size for 24 hours in closed chest coronary embolised dogs. Basic Res Cardiol 80: 76-87.